Stout NL, Wagner SS. Antineoplastic therapy side effects and polypharmacy in older adults with cancer. Top Geriatr Rehabil. 2019;35(1):15–30. https://doi.org/10.1097/TGR.0000000000000212.

Article  PubMed  PubMed Central  Google Scholar 

Sohail MF, Rehman M, Sarwar HS, Naveed S, Salman O, Bukhari NI, et al. Advancements in the oral delivery of docetaxel: challenges, current state-of-the-art and future trends. Int J Nanomedicine. 2018;13:3145–61. https://doi.org/10.2147/ijn.S164518.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ashtarinezhad A, Panahyab A, Vatanpour H, Shirazi F. FTIR determination of miconazole effects on mice fetus brain tissue. Iranian J Pharm Sci. 2014;10(2):79–84.

Google Scholar 

Thirumaran R, Prendergast GC, Gilman PB. Chapter 7 - Cytotoxic chemotherapy in clinical treatment of cancer. In: Prendergast GC, Jaffee EM, editors. Cancer Immunotherapy. Burlington: Academic Press; 2007. p. 101–16.

Chapter  Google Scholar 

Fletcher DA, Mullins RD. Cell mechanics and the cytoskeleton. Nature. 2010;463(7280):485–92. https://doi.org/10.1038/nature08908.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Oshiro C, Marsh S, McLeod H, Carrillo MW, Klein T, Altman R. Taxane pathway. Pharmacogenet Genomics. 2009;19(12):979–83. https://doi.org/10.1097/FPC.0b013e3283335277.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Haldar S, Basu A, Croce CM. Bcl2 is the guardian of microtubule integrity. Cancer Res. 1997;57(2):229–33.

CAS  PubMed  Google Scholar 

Mackler NJ, Pienta KJ. Drug insight: use of docetaxel in prostate and urothelial cancers. Nat Clin Pract Urol. 2005;2(2):92–100.

Article  CAS  Google Scholar 

Eftekhari S, Montazeri H, Tarighi P. Synergistic anti-tumor effects of liraglutide, a glucagon-like peptide-1 receptor agonist, along with Docetaxel on LNCaP prostate cancer cell line. European Journal of Pharmacology. 2020;878:173102.

Jain S, Spandana G, Agrawal AK, Kushwah V, Thanki K. Enhanced antitumor efficacy and reduced toxicity of docetaxel loaded estradiol functionalized stealth polymeric nanoparticles. Mol Pharm. 2015;12(11):3871–84.

Article  CAS  Google Scholar 

Taheri-Ledari R, Zhang W, Radmanesh M, Mirmohammadi SS, Maleki A, Cathcart N, et al. Multi-stimuli nanocomposite therapeutic: docetaxel targeted delivery and synergies in treatment of human breast cancer tumor. Small. 2020;16(41):2002733.

Article  CAS  Google Scholar 

Maloney SM, Hoover CA, Morejon-Lasso LV, Prosperi JR. Mechanisms of taxane resistance. Cancers. 2020;12(11):57. https://doi.org/10.3390/cancers12113323.

Article  CAS  Google Scholar 

Nøhr-Nielsen A, Bagger SO, Brünner N, Stenvang J, Lund TM. Pharmacodynamic modelling reveals synergistic interaction between docetaxel and SCO-101 in a docetaxel-resistant triple negative breast cancer cell line. European Journal of Pharmaceutical Sciences. 2020;148:105315.

Pucci P, Rescigno P, Sumanasuriya S, de Bono J, Crea F. Hypoxia and noncoding RNAs in taxane resistance. Trends Pharmacol Sci. 2018;39(8):695–709. https://doi.org/10.1016/j.tips.2018.05.002.

Article  CAS  PubMed  Google Scholar 

Guo YF, Zhao S, Qiu HH, Wang T, Zhao YN, Han MH, et al. Shape of nanoparticles as a design parameter to improve docetaxel antitumor efficacy. Bioconjug Chem. 2018;29(4):1302–11. https://doi.org/10.1021/acs.bioconjchem.8b00059.

Article  CAS  PubMed  Google Scholar 

Panda J, Satapathy BS, Mandal B, Sen R, Mukherjee B, Sarkar R, et al. Anticancer potential of docetaxel-loaded cobalt ferrite nanocarrier: an in vitro study on MCF-7 and MDA-MB-231 cell lines. J Microencapsul. 2021;38(1):36–46. https://doi.org/10.1080/02652048.2020.1842529.

Article  CAS  PubMed  Google Scholar 

Hu Y, Ran M, Wang B, Lin Y, Cheng Y. Co-delivery of docetaxel and curcumin via nanomicelles for enhancing anti-ovarian cancer treatment. 2020;15:9703-15. https://doi.org/10.2147/ijn.s274083.

Dawoud M, Abourehab MA, Abdou R. Monoolein cubic nanoparticles as novel carriers for docetaxel. J Drug Deliv Sci Technol. Part A. 2020;56:101501. https://doi.org/10.1016/j.jddst.2020.101501.

Dong Z, Shen Y, Zhao S, Wang X, Han M, Zhao N et al. Influence of hydrophobic chains in nanocarriers on antitumor efficacy of docetaxel nanoparticles. 2020;17(4):1205-14. https://doi.org/10.1021/acs.molpharmaceut.9b01228.

Li N, Mai Y, Liu Q, Gou G, Yang J. Docetaxel-loaded D-α-tocopheryl polyethylene glycol-1000 succinate liposomes improve lung cancer chemotherapy and reverse multidrug resistance. Drug Deliv Transl Res. 2021;11(1):131–41. https://doi.org/10.1007/s13346-020-00720-9.

Article  CAS  PubMed  Google Scholar 

Ding Y, Ding Y, Wang Y, Wang C, Gao M, Xu Y, et al. Soluplus(®)/TPGS mixed micelles for co-delivery of docetaxel and piperine for combination cancer therapy. Pharm Dev Technol. 2020;25(1):107–15. https://doi.org/10.1080/10837450.2019.1679834.

Article  CAS  PubMed  Google Scholar 

Talkar SS, Kharkar PB, Patravale VB. Docetaxel loaded pomegranate seed oil based nanostructured lipid carriers: a potential alternative to current formulation. AAPS PharmSciTech. 2020;21(8):295. https://doi.org/10.1208/s12249-020-01839-1.

Article  CAS  PubMed  Google Scholar 

Ghamkhari A, Abbasi F, Abbasi E, Ghorbani M. A novel thermo-responsive system based on β-cyclodextrin-nanocomposite for improving the docetaxel activity. Int J Polym Mater Polym Biomater. 2020:1–11. https://doi.org/10.1080/00914037.2020.1765357.

Gong F, Wang R, Zhu Z, Duan J, Teng X, Cui Z-K. Drug-interactive mPEG-b-PLA-Phe(Boc) micelles enhance the tolerance and anti-tumor efficacy of docetaxel. Drug Delivery. 2020;27(1):238–47. https://doi.org/10.1080/10717544.2020.1718245.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Attia MF, Anton N, Wallyn J, Omran Z, Vandamme TF. An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites. J Pharm Pharmacol. 2019;71(8):1185–98. https://doi.org/10.1111/jphp.13098.

Article  CAS  PubMed  Google Scholar 

He C, Cai P, Li J, Zhang T, Lin L, Abbasi AZ, et al. Blood-brain barrier-penetrating amphiphilic polymer nanoparticles deliver docetaxel for the treatment of brain metastases of triple negative breast cancer. J Control Release. 2017;246:98–109. https://doi.org/10.1016/j.jconrel.2016.12.019.

Article  CAS  PubMed  Google Scholar 

Gao J, Liu J, Xie F, Lu Y, Yin C, Shen X. Co-delivery of docetaxel and salinomycin to target both breast cancer cells and stem cells by PLGA/TPGS nanoparticles. Int J Nanomedicine. 2019;14:9199–216. https://doi.org/10.2147/IJN.S230376.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoang B, Ernsting MJ, Roy A, Murakami M, Undzys E, Li SD. Docetaxel-carboxymethylcellulose nanoparticles target cells via a SPARC and albumin dependent mechanism. Biomaterials. 2015;59:66–76. https://doi.org/10.1016/j.biomaterials.2015.04.032.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vardhan H, Mittal P, Adena SK, Mishra B. Long-circulating polyhydroxybutyrate-co-hydroxyvalerate nanoparticles for tumor targeted docetaxel delivery: formulation, optimization and in vitro characterization. European journal of pharmaceutical sciences: official journal of the European Federation for Pharmaceutical Sciences. 2017;99:85-94. https://doi.org/10.1016/j.ejps.2016.12.007.

Marcinkowska M, Stanczyk M, Janaszewska A, Gajek A, Ksiezak M, Dzialak P, et al. Molecular mechanisms of antitumor activity of PAMAM dendrimer conjugates with anticancer drugs and a monoclonal antibody. Polymers. 2019;11(9):16. https://doi.org/10.3390/polym11091422.

Article  CAS  Google Scholar 

Ashrafizadeh M, Ahmadi Z, Mohamadi N, Zarrabi A, Abasi S, Dehghannoudeh G, et al. Chitosan-based advanced materials for docetaxel and paclitaxel delivery: recent advances and future directions in cancer theranostics. Int J Biol Macromol. 2020;145:282–300. https://doi.org/10.1016/j.ijbiomac.2019.12.145.

Article  CAS  PubMed  Google Scholar 

Mirzaie ZH, Irani S, Mirfakhraie R, Atyabi SM, Dinarvand M, Dinarvand R, et al. Docetaxel-chitosan nanoparticles for breast cancer treatment: cell viability and gene expression study. Chem Biol Drug Des. 2016;88(6):850–8. https://doi.org/10.1111/cbdd.12814.

Article  CAS  PubMed  Google Scholar 

Wang H, Xu Y, Zhou X. Docetaxel-loaded chitosan microspheres as a lung targeted drug delivery system: in vitro and in vivo evaluation. Int J Mol Sci. 2014;15(3):3519–32. https://doi.org/10.3390/ijms15033519.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee E, Kim H, Lee I-H, Jon S. In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration. J Control Release. 2009;140(2):79–85. https://doi.org/10.1016/j.jconrel.2009.08.014.

Article  CAS